Clindamycin 100 mg + Clotrimazole 200 mg is a combination formulation commonly used in vaginal infections where both bacterial and fungal organisms are involved. This dual-action therapy provides broad-spectrum antimicrobial coverage to effectively treat mixed infections such as bacterial vaginosis and candidal vulvovaginitis. Clindamycin is a lincosamide antibiotic that works by inhibiting bacterial protein synthesis, thereby stopping the growth of susceptible anaerobic bacteria and other pathogens associated with bacterial vaginosis. Clotrimazole is an imidazole antifungal agent that disrupts fungal cell membrane integrity by inhibiting ergosterol synthesis, effectively eliminating Candida species and relieving symptoms like itching, burning, and discharge. This combination ensures faster symptom relief, reduces recurrence risk, and restores healthy vaginal flora balance. It is commonly available in vaginal suppository, tablet, or pessary form for local administration.
